Related Experiment Video
Updated: Aug 8, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Correction of Psychoemotional Disorders and Short-Term Prognosis in Patients with COVID-19
V N Shishkova1, K E Imamgayazova1, L A Kapustina1
1National Medical Research Center for Therapeutic and Preventive Medicine, Russian Ministry of Health, Moscow, Russia.
Insights
Psychoemotional factors significantly impact chronic noncommunicable diseases, including cardiovascular disease (CVD). Managing these conditions requires interdisciplinary approaches, especially with COVID-19 complications.
Area of Science:
- Psychiatry and Cardiology
- Epidemiology of Noncommunicable Diseases
- Infectious Diseases and Mental Health
Background:
- Psychoemotional factors are key risks for chronic noncommunicable diseases (NCDs).
- Anxiety and depressive disorders are prevalent in cardiovascular disease (CVD) patients.
- The interplay between mental health and CVD requires further investigation.
Purpose of the Study:
- To review the role of psychoemotional risk factors in NCD development.
- To summarize data on anxiety and depression in CVD patients.
- To explore management strategies and pathogenetic mechanisms, including those related to COVID-19.
Main Methods:
- Literature review of psychoemotional risk factors and NCDs.
- Analysis of prevalence data for anxiety and depressive disorders in CVD.
- Examination of pathogenetic mechanisms and therapeutic interventions.
Main Results:
- Psychoemotional disorders are closely linked to CVD development and complications.
- COVID-19 can cause central nervous system (CNS) damage, exacerbating comorbid conditions.
- Fluvoxamine showed promise in multicenter trials for COVID-19 patients.
Conclusions:
- Interdisciplinary cooperation is crucial for managing patients with comorbid mental and somatic diseases.
- Pathogenetic therapy selection is vital, particularly during the COVID-19 pandemic.
- Further research into psychoemotional well-being's impact on NCDs is warranted.
Abstract:
This review discusses the importance of the main psychoemotional risk factors for the development of chronic noncommunicable diseases. Current data on the prevalence of anxiety and depressive disorders in patients with cardiovascular disease (CVD) are presented. Data on the relationship between the development of psychoemotional disorders and CVD are summarized and the prospects for managing such patients within the framework of interdisciplinary cooperation are discussed. The main pathogenetic mechanisms for the development of complications, including CNS damage in COVID-19, are considered. The significance of the selection of pathogenetic therapy for patients with comorbid somatic and mental diseases in the context of the COVID-19 pandemic is discussed. Results from multicenter placebo-controlled studies of the use of fluvoxamine in patients with COVID-19 of varying severity are addressed.
More Related Videos
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Acute Coronary Syndrome IV: Interprofessional Care
Psychosis: Goals of Pharmacotherapy
Personality Disorders: Paranoid and Schizoid
Paranoid Personality Disorder
Paranoid personality disorder is...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Depression: Overview